Aeterna Faces Shareholder Suit Over Growth Hormone Drug
Aeterna Zentaris Inc. was hit with a putative class action in New Jersey federal court on Wednesday claiming that the Canadian pharmaceutical company inflated its stock by misleading the investing public...To view the full article, register now.
Already a subscriber? Click here to view full article